Creating dermatology guidelines for COVID-19: The pitfalls of applying evidence-based medicine to an emerging infectious disease

J Am Acad Dermatol. 2020 Jun;82(6):e231-e232. doi: 10.1016/j.jaad.2020.04.002. Epub 2020 Apr 9.

Authors

Esther E Freeman¹, Devon E McMahon²

Affiliations

¹ Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Medical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: efreeman@mgh.harvard.edu.
² Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
Communicable Diseases, Emerging*
Coronavirus Infections
Dermatology*
Evidence-Based Medicine
Humans
Pandemics
Pneumonia, Viral
SARS-CoV-2
United States